Revogene Carba C 410500
Revogene Carba C 410500 is a multiple antimicrobial resistance nucleic acid IVD (FDA Class II) made by Meridian Bioscience Inc., cleared under FDA 510(k) K190275 on 10 May 2019 and listed in FDA GUDID since 15 Jul 2020 (UDI-DI 00840733102370), active as of 8 Nov 2026.
Active
510(k)
Valid until
No expiry
FDA recalls
None found
Documents
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | GUDID listing | Number00840733102370 | Date15 Jul 2020 | StatusListed |
| United States | FDA 510(k)SESE | NumberK190275 | Date10 May 2019 | StatusActive |
Official records
- AccessGUDID record 00840733102370
- FDA 510(k) database K190275
From the FDA record
- Device description
- The revogene Carba assay performed on the revogene instrument is a qualitative in vitro diagnostic test designed for the detection and differentiation of the blaKPC, blaNDM, blaVIM, blaOXA-48-like and blaIMP gene sequences associated with carbapenem-non-susceptible pure colonies of Enterobacteriaceae, Acinetobacter baumannii, or Pseudomonas aeruginosa, when grown on blood agar or MacConkey agar. The revogene Carba C assay is intended as an aid for infection control in the detection of carbapenem-non-susceptible bacteria that colonize patients in healthcare settings.
- MRI safety
- Labeling does not contain MRI Safety Information
- Natural rubber latex
- No latex statement on the label
- Sterility
- Supplied non-sterile
Across registries
- FDA 510(k) K190275 decided 10 May 2019 Active
- FDA GUDID UDI-DI 00840733102370 listed 15 Jul 2020 Listed
Timeline
- Cleared FDA 510(k) K190275
- Listed FDA GUDID 00840733102370
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- Trade name
- Revogene Carba C
- Generic name
- Multiple antimicrobial resistance nucleic acid IVD, kit, nucleic acid technique (NAT)
- Model / Ref / Catalog
- 410500
- Primary DI / UDI-DI
- 00840733102370
- 510(k) Number
- FDA product code
- PMY, OOI
- GMDN term
- Multiple antimicrobial resistance nucleic acid IVD, kit, nucleic acid technique (NAT)
- Device class
- Class II
- Regulation number
- 866.1640, 862.2570
- GUDID distribution status
- In Commercial Distribution
Similar devices
Other devices filed under FDA product code OOI.
- Xpert Carba-R by CEPHEID
- GenePOC Carba by Genepoc, Inc.
- Acuitas AMR Gene Panel by Opgen, Inc.
- Simplexa COVID-19 / Flu A/B & RSV Direct MOL4450 by DiaSorin Molecular LLC
- Panther Fusion® KIT, GBS CONTROLS, FUSION, IVD PRD-04485 by Hologic
- QIAstat-Dx® Rise 1 9003163 by QIAGEN GmbH
- Savanna 20382 by DIAGNOSTIC HYBRIDS, INC.
- Alinity m 09N50-001 by Abbott Molecular
- BD Viper LT System by Becton, Dickinson and Company
- ROTOR-GENE Q MDX by QIAGEN GmbH